You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphocytic leukemia

Showing 1 - 25 of 6,274
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • (no location specified)
Nov 22, 2023

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Jul 19, 2023

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 20, 2023

    Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Questionnaires
    • Fit Bit
    • Houston, Texas
      M D Anderson Cancer Center
    May 18, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Not yet recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)

    Recruiting
    • B-cell Acute Lymphocytic Leukemia
    • CD19 CAR-T cells
    • Suzhou, China
      The First Affiliated Hospital of Soochow University
    Jan 11, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Leukemia
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

    Recruiting
    • CLL/SLL
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital Affiliate
    Jun 16, 2023

    Understanding Chronic Lymphocytic Leukemia

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Aug 1, 2022

      Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

      Not yet recruiting
      • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
      • Zhoukou, Henan, China
      • +1 more
      Dec 22, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Leukemia
      • (no location specified)
      Nov 30, 2022

      Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

      Not yet recruiting
      • Myeloid Malignancies
      • +3 more
      • (no location specified)
      Mar 22, 2023